Wirtz Petra H, von Känel Roland, Emini Luljeta, Ruedisueli Katharina, Groessbauer Sara, Maercker Andreas, Ehlert Ulrike
Department of Clinical Psychology and Psychotherapy, Psychological Institute, University of Zurich, Binzmuhlestrasse 14/Box 26, CH-8050 Zurich, Switzerland.
Psychoneuroendocrinology. 2007 Jun;32(5):430-6. doi: 10.1016/j.psyneuen.2007.02.006. Epub 2007 Apr 11.
Hypothalamus-pituitary-adrenal (HPA) axis functioning in systemic hypertension is not fully understood. We explored HPA axis activity and feedback sensitivity to oral administration of dexamethasone in systemic hypertension via assessment of the cortisol awakening response (CAR) and the circadian cortisol profile.
The CAR and circadian cortisol profile were assessed in 20 unmedicated and otherwise healthy middle-aged hypertensive men and in 22 normotensive male controls. Salivary free cortisol measures for the CAR were obtained immediately after awakening and 15, 30, 45, and 60 min thereafter. Circadian cortisol secretion was sampled at 08:00, 11:00, 15:00, and 20:00 h. Assessment of the CAR was repeated on the next day after administration of 0.5mg dexamethasone at 23:00 h on the previous night.
Hypertensives had a significantly lower CAR (p<0.02) and significantly reduced suppression of the CAR after dexamethasone administration (p<0.01) than normotensive controls. There were no significant differences in cortisol levels at awakening and in circadian cortisol profiles between hypertensives and normotensives.
We found evidence for altered HPA axis activity in men with systemic hypertension evident with the CAR. Hypertensives showed relative attenuation in the CAR and in the HPA axis feedback sensitivity following dexamethasone suppression. Such alterations in HPA axis regulation might contribute to the atherosclerotic risk in hypertensive individuals.
下丘脑 - 垂体 - 肾上腺(HPA)轴在系统性高血压中的功能尚未完全明确。我们通过评估皮质醇觉醒反应(CAR)和昼夜皮质醇谱,探讨系统性高血压患者口服地塞米松后的HPA轴活性及反馈敏感性。
对20名未接受药物治疗的健康中年男性高血压患者和22名血压正常的男性对照者进行CAR和昼夜皮质醇谱评估。在觉醒后即刻及随后的15、30、45和60分钟采集唾液游离皮质醇用于CAR测定。在08:00、11:00、15:00和20:00采集昼夜皮质醇分泌样本。在前一晚23:00给予0.5mg地塞米松后次日重复CAR评估。
与血压正常的对照组相比,高血压患者的CAR显著降低(p<0.02),且地塞米松给药后CAR的抑制作用显著减弱(p<0.01)。高血压患者和血压正常者在觉醒时的皮质醇水平及昼夜皮质醇谱无显著差异。
我们发现系统性高血压男性患者的HPA轴活性改变,这在CAR中表现明显。高血压患者在CAR及地塞米松抑制后的HPA轴反馈敏感性方面呈现相对减弱。HPA轴调节的这种改变可能导致高血压个体的动脉粥样硬化风险增加。